Clinical Trials for AML - Acute Myeloid Leukemia

Find clinical trials for aml - acute myeloid leukemia. Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation

NCT ID: NCT07025824

This clinical trial is studying two different chemotherapy treatments given before a stem cell transplant for people with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS). The goal is...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Kiel, , Germany, Dresden, , Germany +2 more

Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX

NCT ID: NCT06782971

This clinical trial is focused on finding new ways to treat patients with Acute Myeloid Leukemia (AML), a type of cancer that affects the blood and bone marrow. Researchers want to see if they can ...

Recruiting

Type: observational Locations: Westmead, New South Wales, Australia, Sydney, New South Wales, Australia +2 more

A Study of CBX-250 in Participants With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

NCT ID: NCT06994676

This clinical trial, called Study CBX-250-001, is exploring a new drug called CBX-250 for individuals aged 12 and older who have certain types of blood cancers, specifically acute myeloid leukemia ...

Not yet recruiting

Phase: PHASE1 Type: interventional

A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Venetoclax-based Low-Intensity Therapy (LIT) in Treatment-Naïve Acute Myeloid Leukemia (AML): DLIT-AML

NCT ID: NCT07014462

This clinical trial, called DLIT-AML, is exploring the safety and how well patients tolerate a new treatment for people with Acute Myeloid Leukemia (AML) who have not received any prior treatment. ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Burlington, Vermont, United States

Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment

NCT ID: NCT06696183

This clinical trial is studying a new combination treatment for patients with Acute Myeloid Leukemia (AML) who have a specific genetic change called a FLT3 mutation. The researchers want to find ou...

Recruiting

Phase: PHASE2 Type: interventional Locations: Dresden, , Germany

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions